scholarly article | Q13442814 |
P2093 | author name string | Kullberg BJ | |
van 't Wout JW | |||
van Furth R | |||
P2860 | cites work | A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection | Q24654068 |
Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition | Q33449039 | ||
Shock and tissue injury induced by recombinant human cachectin | Q34189904 | ||
Enhancement of antibacterial resistance of neutropenic, bone marrow-suppressed mice by interleukin-1 alpha | Q35088444 | ||
Separate and combined effects of recombinant interleukin-1 alpha and gamma interferon on antibacterial resistance | Q35090879 | ||
Multiple biological activities of human recombinant interleukin 1. | Q36993845 | ||
Recombinant murine interleukin-1 alpha enhancement of nonspecific antibacterial resistance | Q37022333 | ||
Efficacy of interleukin-1 beta against systemic Candida albicans infections in normal and immunosuppressed mice. | Q37025433 | ||
Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1a | Q40163394 | ||
Interleukin-1. | Q40173633 | ||
Comparison of the effects of recombinant interleukin 6 and recombinant interleukin 1 on nonspecific resistance to infection | Q41260496 | ||
The effects of recombinant interleukin-1 and recombinant tumor necrosis factor on non-specific resistance to infection | Q41872712 | ||
Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy | Q43988777 | ||
Effect of irradiation, cyclophosphamide, and etoposide (VP-16) on number of peripheral blood and peritoneal leukocytes in mice under normal conditions and during acute inflammatory reaction | Q45151589 | ||
Effects of murine recombinant interleukin 1 alpha on the host response to bacterial infection | Q48121412 | ||
Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infection. | Q54372357 | ||
Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1. | Q54380601 | ||
Purified human and recombinant murine interleukin-1 alpha induced accumulation of inflammatory peritoneal neutrophils and mononuclear phagocytes: possible contributions to antibacterial resistance. | Q54398152 | ||
Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate. | Q54401826 | ||
Modulation of anti-CandidaActivity of Human Alveolar Macrophages by Interferon-gamma or Interleukin-1-alpha | Q63247637 | ||
Interleukin-1 (22-K factor) induces release of granulocyte-macrophage colony-stimulating activity from human mononuclear phagocytes | Q68915452 | ||
Fungicidal activity of murine inflammatory polymorphonuclear neutrophils: comparison with murine peripheral blood PMN | Q68949600 | ||
Enhanced antibacterial resistance in neutropenic mice treated with human recombinant interleukin-1 beta | Q70199343 | ||
Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor | Q72077756 | ||
Candidiasis in cancer patients | Q72400057 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Candida albicans | Q310443 |
host resistance | Q123944447 | ||
P304 | page(s) | 3319-3324 | |
P577 | publication date | 1990-10-01 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1 | |
P478 | volume | 58 |
Q37893650 | Chlamydia trachomatis pneumonia induces in vivo production of interleukin-1 and -6 |
Q35862619 | Combined effect of fluconazole and recombinant human interleukin-1 on systemic candidiasis in neutropenic mice |
Q34117739 | Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans |
Q91722932 | Histone deacetylase inhibitor attenuates experimental fungal keratitis in mice |
Q35550680 | Hyperlipoproteinemia enhances susceptibility to acute disseminated Candida albicans infection in low-density-lipoprotein-receptor-deficient mice |
Q33535878 | IL-1beta processing in host defense: beyond the inflammasomes |
Q38590007 | Immune defence against Candida fungal infections |
Q43163022 | Immune recognition of Candida albicans beta-glucan by dectin-1. |
Q34619615 | Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors |
Q36987907 | In vitro study of contact-mediated killing of Candida albicans hyphae by activated murine peritoneal macrophages in a serum-free medium |
Q40899109 | Interleukin-1 as a possible agent for treatment of infection |
Q38666235 | Interleukin-1 function and role in rheumatic disease |
Q35772838 | Interleukin-1 is involved in mouse resistance to Mycobacterium avium. |
Q36574240 | Macrophages in resistance to candidiasis |
Q60935590 | NLRP3-Dependent and -Independent Processing of Interleukin (IL)-1β in Active Ulcerative Colitis |
Q67792168 | No effect of recombinant human interleukin-1 on numbers of peripheral blood and peritoneal leukocytes during acute inflammation |
Q36112280 | Novel nanoscale bacteriophage-based single-domain antibodies for the therapy of systemic infection caused by Candida albicans |
Q33665408 | Proinflammatory chemokines during Candida albicans keratitis |
Q34851532 | Protective host defense against disseminated candidiasis is impaired in mice expressing human interleukin-37. |
Q37643830 | Role of Dectin-2 for host defense against systemic infection with Candida glabrata. |
Q35780800 | Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice |
Q36786137 | The Role of Dectin-2 for Host Defense Against Disseminated Candidiasis |
Q37612479 | The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis. |
Q34230759 | Treatment of intra-abdominal abscesses caused by Candida albicans with antifungal agents and recombinant murine granulocyte colony-stimulating factor |
Q41377990 | Trends in immunotherapy of fungal infections |
Q36951405 | Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice |
Q36133627 | Use of immune modulators in nonspecific therapy of bacterial infections |
Search more.